Burden of disease at the same limit of exposure to airborne polycyclic aromatic hydrocarbons varies significantly across countries depending on the gap in longevity.

[1]  A. Pozzer,et al.  Age-dependent health risk from ambient air pollution: a modelling and data analysis of childhood mortality in middle-income and low-income countries. , 2018, The Lancet. Planetary health.

[2]  A. Pillarisetti,et al.  The gains in life expectancy by ambient PM2.5 pollution reductions in localities in Nigeria. , 2018, Environmental pollution.

[3]  K. Krishnamurthi,et al.  The burden of disease attributable to ambient PM2.5-bound PAHs exposure in Nagpur, India. , 2018, Chemosphere.

[4]  Matthew L. Thomas,et al.  Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015 , 2017, The Lancet.

[5]  A. Pillarisetti,et al.  The health burden and economic costs averted by ambient PM2.5 pollution reductions in Nagpur, India. , 2017, Environment international.

[6]  Thomas Pfister,et al.  Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals. , 2016, Regulatory toxicology and pharmacology : RTP.

[7]  Jinglan Hong,et al.  Air pollution from polycyclic aromatic hydrocarbons generated by human activities and their health effects in China , 2016 .

[8]  M. Huijbregts,et al.  Carcinogenic Air Toxics Exposure and Their Cancer-Related Health Impacts in the United States , 2015, PloS one.

[9]  A. Wilt,et al.  Pure B-Cell Disorders , 2015 .

[10]  Anna C. Salzberg,et al.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead , 2015, Carcinogenesis.

[11]  Wei Li,et al.  Global lung cancer risk from PAH exposure highly depends on emission sources and individual susceptibility , 2014, Scientific Reports.

[12]  Rebecca Klemm,et al.  Public health and components of particulate matter: The changing assessment of black carbon , 2014, Journal of the Air & Waste Management Association.

[13]  Fred A. Wright,et al.  Standardizing Benchmark Dose Calculations to Improve Science-Based Decisions in Human Health Assessments , 2014, Environmental health perspectives.

[14]  S. Wate,et al.  Influence of seasonal variation on water quality in tropical water distribution system: is the disease burden significant? , 2014, Water research.

[15]  Ki-Hyun Kim,et al.  A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. , 2013, Environment international.

[16]  F. Dominici,et al.  Evidence on vulnerability and susceptibility to health risks associated with short-term exposure to particulate matter: a systematic review and meta-analysis. , 2013, American journal of epidemiology.

[17]  K. Sun,et al.  Global atmospheric emissions of polycyclic aromatic hydrocarbons from 1960 to 2008 and future predictions. , 2013, Environmental science & technology.

[18]  Satish R Wate,et al.  Prioritizing hazardous pollutants in two Nigerian water supply schemes: a risk-based approach. , 2013, Bulletin of the World Health Organization.

[19]  M. Sinclair,et al.  Using disability-adjusted life years to set health-based targets: A novel use of an established burden of disease metric , 2013, Journal of public health policy.

[20]  Ian Roberts,et al.  The weight of nations: an estimation of adult human biomass , 2012, BMC Public Health.

[21]  Douglas Crawford-Brown,et al.  Cumulative Risk Assessment Framework for Waterborne Contaminants , 2012 .

[22]  Who Regional Office for Europe,et al.  WHO Guidelines for Indoor Air Quality: Selected Pollutants , 2011 .

[23]  F. Borrull,et al.  Risk Assessment Related to Atmospheric Polycyclic Aromatic Hydrocarbons in Gas and Particle Phases near Industrial Sites , 2011, Environmental health perspectives.

[24]  S. Franceschi,et al.  Estrogen and ERα: Culprits in cervical cancer? , 2010, Trends in Endocrinology & Metabolism.

[25]  S. Tao,et al.  Inhalation exposure to ambient polycyclic aromatic hydrocarbons and lung cancer risk of Chinese population , 2009, Proceedings of the National Academy of Sciences.

[26]  E. V. Sargent,et al.  Investigations of the use of bioavailability data to adjust occupational exposure limits for active pharmaceutical ingredients. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  M. Huijbregts,et al.  Confronting environmental pressure, environmental quality and human health impact indicators of priority air emissions , 2009 .

[28]  Charlotte Paul,et al.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. , 2008, The Lancet. Oncology.

[29]  W. Stubblefield,et al.  Predicting the toxicity of neat and weathered crude oil: Toxic potential and the toxicity of saturated mixtures , 2007, Environmental toxicology and chemistry.

[30]  G. Pearse.  Histopathology of the Thymus , 2006, Toxicologic pathology.

[31]  M. Kottow.  The Vulnerable and the Susceptible , 2003, Bioethics.

[32]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[33]  O. Jolliet,et al.  Assessing Human Health Response in Life Cycle Assessment Using ED10s and DALYs: Part 2—Noncancer Effects , 2002, Risk analysis : an official publication of the Society for Risk Analysis.

[34]  T. Shirakawa,et al.  Genetic polymorphisms and lung cancer susceptibility: a review. , 2002, Lung cancer.

[35]  Christer Johansson,et al.  Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. , 2002, Environmental health perspectives.

[36]  A. Dahl,et al.  The rapid alveolar absorption of diesel soot-adsorbed benzo[a]pyrene: bioavailability, metabolism and dosimetry of an inhaled particle-borne carcinogen. , 2001, Carcinogenesis.

[37]  A. Miller,et al.  Natural history of dysplasia of the uterine cervix. , 1999, Journal of the National Cancer Institute.

[38]  J. Lewis,et al.  Benzo[a]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in, tracheal epithelium. , 1997, Carcinogenesis.

[39]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[40]  M. Roller,et al.  Estimation of a lifetime unit lung cancer risk for benzo(a)pyrene based on tumour rates in rats exposed to coal tar/pitch condensation aerosol. , 1994, Toxicology letters.

[41]  Mark D. Hoover,et al.  Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog. I. The alveolar region. , 1993, Toxicology and applied pharmacology.

[42]  R. Anzion,et al.  Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. , 1990, British journal of industrial medicine.

[43]  A I Nikiforov,et al.  A new approach to deriving community exposure guidelines from "no-observed-adverse-effect levels". , 1990, Regulatory toxicology and pharmacology : RTP.

[44]  J. A. Bond,et al.  Effects of adsorption of benzo[a]pyrene onto carbon black particles on levels of DNA adducts in lungs of rats exposed by inhalation. , 1989, Toxicology and applied pharmacology.

[45]  F. Jongeneelen.  Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. , 2001, The Annals of occupational hygiene.

[46]  N. Benowitz,et al.  Cotinine as a biomarker of environmental tobacco smoke exposure. , 1996, Epidemiologic reviews.

[47]  J. Lodge.  Air quality guidelines for Europe: WHO regional publications, European series, No. 23, World Health Organization, 1211 Geneva 27, Switzerland; WHO publications center USA, 49 Sheridan Avenue, Albany, NY 12210, 1987, xiii + 426 pp. price: Sw. fr. 60 , 1988 .